Beta blockers and the primary prevention of nonfatal myocardial infarction in patients with high blood pressure
- 6 November 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (16), G12-G14
- https://doi.org/10.1016/0002-9149(90)90386-f
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood PressurePublished by American Medical Association (AMA) ,1989
- Circadian variation and triggers of onset of acute cardiovascular disease.Circulation, 1989
- Primary Prevention With Metoprolol in Patients With HypertensionJAMA, 1988
- Beta-Blockers Versus Diuretics in Hypertensive Men: Main Results from the HAPPHY TrialJournal Of Hypertension, 1987
- The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trialsProgress in Cardiovascular Diseases, 1986
- Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)Journal Of Hypertension, 1985
- MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.BMJ, 1985
- β-Adrenoceptor antagonists and human platelets: relationship of effects to lipid solubilityBiochemical Pharmacology, 1984
- Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug ProjectNew England Journal of Medicine, 1980
- A pitfall in sampling medical visits.American Journal of Public Health, 1977